Partial anomalous pulmonary venous return (PAPVR) is a rare congenital vascular anomaly. In this condition, one or more pulmonary veins drain into the systemic venous system rather than the left atrium. When patients present with concurrent primary lung cancer, surgeons face a complex clinical challenge. Specifically, they must decide if the patient requires vascular reconstruction alongside pulmonary resection. Recent research highlights the pulmonary-to-systemic flow ratio as a critical physiological indicator for this decision-making process.

Understanding the Surgical Challenge

Surgeons often detect PAPVR incidentally during preoperative imaging for lung cancer. If the malignancy and the anomalous vein reside in different lobes, the surgery becomes riskier. Removing a lung lobe can shift hemodynamics significantly. Consequently, the remaining lung tissue must handle an increased blood volume. This sudden shift might exacerbate the existing left-to-right shunt. Therefore, accurate preoperative and intraoperative assessments are vital to prevent postoperative right heart failure.

Clinical Utility of the Pulmonary-to-Systemic Flow Ratio

The pulmonary-to-systemic flow ratio (Qp/Qs) measures the degree of shunting between the pulmonary and systemic circulations. In a healthy heart, this ratio remains approximately 1.0. Clinical experts generally consider a ratio above 1.5 as hemodynamically significant. In a recent study involving two patients, surgeons used intraoperative measurements to guide their interventions. One patient showed a ratio of 1.06, suggesting a negligible shunt. Consequently, the team performed the lung resection without vascular repair. In contrast, the second patient had a ratio of 2.20. Because this high ratio indicated a severe risk of heart failure, the surgeons performed both the cancer resection and a PAPVR repair.

The Impact of Advanced Imaging

The growing use of three-dimensional computed tomography (3D CT) has improved the detection of vascular anomalies. 3D CT allows for precise anatomical mapping before the first incision. This technology helps clinicians identify PAPVR even when it remains asymptomatic. By combining anatomical data from 3D CT with functional data from the flow ratio, surgical teams can customize their approach for each patient. This dual assessment ensures oncological radicality while preserving cardiovascular stability. Both patients in the study recovered well and left the hospital without any cardiovascular complications.

Frequently Asked Questions

What is a significant pulmonary-to-systemic flow ratio?

In clinical practice, a Qp/Qs ratio greater than 1.5 or 2.0 typically indicates a hemodynamically significant shunt. High ratios often require surgical correction to prevent long-term complications like pulmonary hypertension or right heart strain.

Why is PAPVR a concern during lung cancer surgery?

If a surgeon removes lung tissue in a patient with PAPVR, the blood flow to the remaining lobes increases. This can worsen the volume overload on the right side of the heart, potentially leading to acute postoperative heart failure.

Can 3D CT replace flow ratio measurements?

While 3D CT provides excellent anatomical detail, it does not measure blood flow. The flow ratio provides the functional data needed to determine if an anatomical anomaly is actually causing physiological stress.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Clinicians should refer to the latest local and national guidelines for clinical practice.

References

1. Matsudo K et al. Pulmonary-to-systemic flow ratio: lung cancer with partial anomalous pulmonary venous return. Gen Thorac Cardiovasc Surg. 2026 Apr 19. doi: 10.1007/s11748-026-02301-y. PMID: 42001388.


2. Singhal K et al. Management of partial anomalous pulmonary venous connections in patients requiring pulmonary resection. J Thorac Dis. 2017;9(12):5359-5363.


3. Geva T. Management of Partial Anomalous Pulmonary Venous Return. UpToDate. 2024.